Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-25-003585

Options or other derivatives

  • Chief Financial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ABRAMS MICHAEL S Chief Financial Officer 2025-02-07 Grant or award · Stock Option (right to buy) +50,000 50,000 D
Loading xslF345X05/form4-02112025_050201.xml…